Table 3.

Predicted antigenic B-cell epitopes of SARS-CoV-2 Nsp13 helicase protein.

No.	Start	End	Peptide	Length
3	70	75	YYCKSH	6
5	207	212	DAVVYR	6
10	369	374	DIVVFD	6
11	384	389	LSVVNA	6
13	423	428	NSVCRL	6
15	493	498	IGVVRE	6
17	542	547	DYVIFT	6
12	394	400	KHYVYIG	7
16	522	528	ASKILGL	7
18 *	570	576	VGILCIM	7
1	4	11	ACVLCNSQ	8
6	222	230	GDYFVLTSH	9
9	353	361	EQYVFCTVN	9
4	78	87	PISFPLCANG	10
14	449	458	VDTVSALVYD	10
7	237	250	APTLVPQEHYVRIT	14
8	292	325	AIGLALYYPSARIVYTACSHAAVDALCEKALKYL	34
2	21	58	RRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVT	38

* 18 antigenic sites were predicted. The underlined residues were also predicted as CTL epitope.